• Shuttle Pharmaceuticals received a Nasdaq noncompliance notice for missing the Form 10-Q filing deadline for the quarter ended June 30, 2026.
• The late filing breaches Nasdaq Listing Rule 5250(c)(1), raising delisting risk if compliance is not restored.
• A remediation plan is due by Oct. 27, 2026; Nasdaq may grant an exception through Feb. 22, 2027.
• Trading continues for now, though a noncompliance indicator will be disseminated and the issuer will appear on Nasdaq’s list around Sept. 4, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608281605NEWSFILECNPR____20260828_311980_1) on August 28, 2026, and is solely responsible for the information contained therein.